back to homepage

List of Posters

P-01: IN VITRO AND IN SILICO EVALUATION OF A NEW SERIES OF PYRAZOLINES AS CHOLINESTERASE INHIBITORS
M. D. Altıntop

P-02: DEVELOPMENT OF NOVEL H2S-DONOR SIGMA RECEPTOR HYBRIDS FOR THE MANAGEMENT OF PAIN
M. Dichiara, C. Pitino, C. Barbaraci, A. Artacho-Cordón, E. J. Cobos, A. Marrazzo, and E. Amata

P-03: 5-ALKYLAMINO-N-PHENYLPYRAZINE-2-CARBOXAMIDES AS POTENTIAL ANTIMYCOBACTERIAL AGENTS
W. Ambrożkiewicz and J. Zitko

P-04: BJ-1301, A NOX2 AND RECEPTOR TYROSINE KINASE INHIBITOR, SUPRESSING AUTOCRINE-STIMULATORY FACTORS IN LUNG CANCER
B. P. Awasthi, J. Gautam, B.-S. Jeong, and J.-A. Kim

P-05: SYNTHESIS OF LUNG TISSUE RETENTIVE PRODRUGS
J. Ayre, D. Speed, R. Weaver, G. Vitulli, J. Morrell, C. Bosquillon, J. Redmond, and M. J. Stocks

P-06: PROTECTIVE EFFECTS OF 1-BUTYL-3-(5-HYDROXY-3,4,6-TRIMETHYLPYRIDIN-2-YL)THIOUREA AGAINST 4-HNE-INDUCED ADULT RETINAL PIGMENT EPITHELIAL-19 CELL DEATH
D. Bae, J. Gautam, J.-A. Kim, and B.-S. Jeong

P-07: A SMALL MOLECULE INHIBITOR OF TRANSFORMING ACIDIC COILED-COIL PROTEIN 3 (TACC3): A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF BREAST CANCER
D. Lengerli, O. Akbulut, B. Caliskan, O. Sahin, and E. Banoglu

P-08: ABOUT AGGREGATIVE STABILITY OF NANODISPERSIONS BASED ON GADOLINIUMCOMPOUNDS FOR OBTAINING DIAGNOSTIC SYSTEMS
I. A. Belova, V. S. Makulova, K. I. Kienskaya, and M. V. Sardushkin

P-09: MOF COMPOUNDS AS DUAL ACETYL AND BUTYRYLCHOLINESTERASE INHIBITORS
A. M. Bondžić, M. V. Senćanski, A. Vujačić Nikezić, M. V. Kirillova, V. André, A. M. Kirillov, and B. P. Bondzić

P-10: hybrid compounds combining pyrazinamide and p-aminosalicylic acid: Design, synthesis, and antimicrobial evaluation
G. Bouz, M. Doležal, and J. Zitko

P-11: DISCOVERY OF 3-[3-(PYRROLIDIN-1-YL)PROPYL]-1,2-BENZOXAZOLE DERIVATIVES TARGETING BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)
A. Bucki, M. Marcinkowska, J. Śniecikowska, A. Zagórska, M. Pawłowski, M. Głuch-Lutwin, A. Siwek, A. Partyka, M. Jastrzębska-Więsek, A. Wesołowska, P. Mierzejewski, and M. Kołaczkowski

P-12: DESIGN, SYNTHESIS AND MOLECULAR MODELING OF POTENTIAL LIGANDS OF IONOTROPIC GLUTAMATE RECEPTORS
P. Chałupnik and E. Szymańska

P-13: FLUORINE-18 ISOTOPE LABELING FOR POSITRON EMISSION TOMOGRAPHY IMAGING. DIRECT EVIDENCE FOR DBPR211 AS A PERIPHERALLY RESTRICTED CB1 INVERSE AGONIST
C. P. Chang, H. L. Huang, J. K. Huang, M.S. Hung, C. H. Wu, J. S. Song, C. J. Lee, C. S. Yu, and K. S. Shia

P-14: DISCOVERY OF 6-HETEROARYLAMINO-2,4,5-TRIMETHYLPYRIDIN-3-OLS FOR ANTI-INFLAMMATORY BOWEL DISEASE
C. L. Chaudhary, S. W. Park, S. Banskota, T.-G. Nam, J.-A. Kim, and B.-S. Jeong

P-15: NEW CLASS OF TRPA1 ANTAGONISTS AND/OR PDE INHIBITORS BASED ON PURINE-2,6-DIONE SCAFFOLD AS POTENTIAL ANALGESIC AGENTS
G. Chłoń-Rzepa, M. Ślusarczyk, A. Jankowska, A. Bucki, A. Gawalska, M. Pawłowski, A. Świerczek, K. Pociecha, E. Wyska, M. Zygmunt, and G. Kazek

P-16: UB-EV-52, A NEW CHEMICAL PROBE TO ESTABLISH SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR THE TREATMENT OF ALZHEIMER’S DISEASE
S. Codony, C. Griñan-Ferré, E. Pujol, J. Yang, R. Leiva, C. Escolano, D. Puigoriol-Illamola, J. Companys-Alemany, R. Corpas, C. Sanfeliu, C. Morisseau, B. D. Hammock, C. Galdeano, M. Pallàs, and S. Vázquez

P-17: CARBOHYDRATE-BASED POTENTIAL ANTIMICROBIAL DRUGS AND GLYCOPEPTIDES WITH OLD AND NEW THERAPEUTIC GOALS
M. Csávás, L. Malinovská, G. Jančaříková, S. Le Thai, Zs. Szűcs, P. Herczegh, M. Wimmerová, and A. Borbás

P-18: SYNTHESIS OF BIOCONJUGATES OF FERROCENE AND PYRIMIDINE NUCLEOBASES AND CHEMOSENSITIVITY OF HUMAN LUNG EPOTELIAL CELLS
S. Djaković, J. Lapić, M. Toma, D. Šakić, V. Vrček, A. M. Marjanović Čermak, K. Ilić, and I. Pavičić

P-19: ASSOCIATED USE OF HETEROCYCLIC COMPOUNDS WITH CHEMOTHERAPY TO REDUCE SIDE EFFECTS AND INCREASE ANTITUMOR ACTIVITY IN THE EXPERIMENT
M. Dosina, A. Kvachenok, S. Pashkevich, A. Kletskov, V. Potkin, R. Aleksandrova, and V. Kulchitsky

P-20: A NOVEL 3-METHYLIDENEQUINOL-4-ONE DERIVATIVE INDUCES APOPTOSIS AND DOWNREGULATES MAPK PATHWAY IN LEUKEMIA CELL LINE
J. Drogosz, K. Gach-Janczak, A. Długosz-Pokorska, J. Koszuk, and A. Janecka

P-21: RATIONAL DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL HDHODH INHIBITORS
N. C. Fohrmann, K. Pfaff, M. Winkler, G. Querat, J. Kirchmair, and C. Meier

P-22: PROMISING INHIBITORY ACTIVITY OF FLAVONOIDS AGAINST IMPORTANT TARGETS RELATED WITH TYPE 2 DIABETES MELLITUS
C. Proença, M. Freitas, D. Ribeiro, Sara M. Tomé, Alberto N. Araújo, A. M. S. Silva, P. A. Fernandes, and E. Fernandes

P-23: ANTICANCER ACTIVITY OF A NEW α-METHYLENE-δ-LACTONE DL-247 IN SELECTED CANCER CELL LINES
K. Gach-Janczak, A. Długosz-Pokorska, J. Drogosz, R. Jakubowski, J. Szymański, T. Janecki, and A. Janecka

P-24: METAL-CHELATING AGENTS WITH IMPROVED INHIBITORY ACTIVITY AGAINST HEPATITIS C VIRUS
E. Giannakopoulou, V. Pardali, E. Frakolaki, V. Myrianthopoulos, E. Mikros, R. Bartenschlager, N. Vassilaki, and G. Zoidis

P-25: THYMOL 1,3,5-TRIAZINE DERIVATIVES AS NEW POTENT LIGANDS FOR 5-HT6 SEROTONIN RECEPTOR
J. Handzlik, M. Więcek, M. Pikuła, D. Furgał, R. Kurczab, G. Satała, D. Łażewska, and K. Kieć-Kononowicz

P-26: IN VITRO PROFILING OF NEW ANTIMYCOBACTERIAL COMPOUNDS AND THEIR PEPTIDE CONJUGATES
L. Horváth, M. Krátký, Zs. Baranyai, V. Pflégr, J. Vinšová, and Sz. Bősze

P-27: SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVELN-SUBSTITUTED BENZIMIDAZOLE ACRYLONITRILES
M. Hranjec, N. Perin, A. Beč, L. Persoons, and D. Daelemans

P-28: SYNTHESIS OF INDAZOLE-BASED INHIBITORS AS POTENTIAL AGENTS AGAINST ABNORMAL TAU FORMATION
J.-H. Hsu, Y.-F. Liao, and M.-K. Hu

P-29: EXPLORATION OF KINASE INHIBITORS AS AUTOPHAGIC MODULATORS OF Aβ PRODUCTION
M.-K. Hu, Y.-F. Liao, A.-S. Liou, J.-H. Hsu, and F.-C. Yang

P-30: NEW TRPV1 CHANNEL ANTAGONISTS WITH ANTICONVULSANT AND ANTINOCICEPTIVE ACTIVITY
M. Jakubiec, M. Zagaja, M. Andres-Mach, A. Szewczyk, M. Abram, S. Mogilski, G. Latacz, B. Szulczyk, and K. Kamiński

P-31: DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF NOVEL AMINOALKYLAMIDE DERIVATIVES AS 5-HT1A/5-HT7 RECEPTORS LIGANDS AND PHOSPHODIESTERASES 4/7 INHIBITORS
A. Jankowska, G. Satała, M. Kołaczkowski, M. Głuch-Lutwin, A. Bucki, A. Świerczek, K. Pociecha, B. Mordyl, A. Lubelska, G. Latacz, A. Gawalska, M. Jamrozik, A. Partyka, A. Wesołowska, A. J. Bojarski, E. Wyska, J. Handzlik, M. Pawłowski, and G. Chłoń-Rzepa

P-32: NOVEL LIPOPHILIC CAGED ADENOSINE NUCLEOTIDES
N. Jeschik and C. Meier

P-33: SYNTHESIS OF PHOSPHORYLATED 13α-ESTRONE DERIVATIVES AS POTENTIAL OATP2B1 INHIBITORS
R. Jójárt, P. Trungel-Nagy, M. Klement, J. Wölfling, R. Rigó, O. Ungvári, Cs. Özvegy-Laczka, and E. Mernyák

P-34: Design, synthesis and biological evaluation of pyrazine derivatives
M. Juhás, J. Zitko, and M. Doležal

P-35: MULTI-TARGET LIGANDS OF AMINERGIC GPCRS FOR POTENTIAL TREATMENT OF MENTAL DISEASES
Ag. A. Kaczor, M. Kondej, P. Stępnicki, O. Koszła, J. Żuk, A. Bartyzel, K. M. Targowska-Duda, T. M. Wróbel, D. Bartuzi, E. Kędzierska, G. Biała, D. Matosiuk, A. G. Silva, and M. Castro

P-36: AMINE DERIVATIVES OF 5-ARYLIDENEIMIDAZOLONES AS POTENTIAL ANTIBIOTIC ADJUVANTS
An. Kaczor, K. Witek, S. Alibert, J. M. Pages, E. Karczewska, K. Kieć-Kononowicz, and J. Handzlik

P-37: NEW 2-ARYLQUINONES AND THEIR ANTIPLASMODIAL AND TRYPANOCIDAL PROPERTIES
M.-M. Kalt and A. Presser

P-38: STRUCTURE – IN VITRO CARDIOPROTECTIVE ACTIVITY RELATIONSHIPS STUDY OF NOVEL DEXRAZOXANE DERIVATIVES
G. Karabanovich, A. Jirkovská, H. Jansová, T. Šimůnek, and J. Roh

P-39: DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL DERIVATIVES AS TYROSYL-DNA PHOSPHODIESTERASE 1 AND/OR 2 INHIBITORS
M. Karelou, K. Agama, Y. Pommier, and I. K. Kostakis

P-40: ANTI-CANCER ACTIVITY OF 6-(4-(HYDROXYDIPHENYLMETHYL)PIPERIDIN-1-YL)-2,4,5-TRIMETHYLPYRIDIN-3-OL
U. Karmacharya, J. Gautam, B.-S. Jeong, and J.-A. Kim

P-41: MONOAMINE OXIDASE B INHIBITORY ACTIVITY OF 4-IMIDAZOLONE DERIVATIVES
K. Kieć-Kononowicz, A. Olejarz-Maciej, A. Doroz-Płonka, A. Chudzik, T. Rządca, and D. Łażewska

P-42: CAVER WEB: ANALYSIS OF PROTEIN TUNNELS AND LIGAND BINDING TRAJECTORIES IN DRUG DESIGN
P. Kokkonen, J. Stourac, J. Filipovic, O. Vavra, G. Pinto, D. Bednar, and J. Damborsky

P-43: D2AAK1 AS A MULTI-TARGET LIGAND OF AMINERGIC GPCRS – OPTIMIZATION OF SYNTHESIS
M. Kondej, P. Stępnicki, T. M. Wróbel, D. Matosiuk, and A. A. Kaczor

P-44: NEW AGENTS SUPPRESSING MYCOBACTERIUM ABSCESSUS: SMALL MOLECULES AND THEIR PEPTIDE CONJUGATES
M. Krátký, L. Horváth, Zs. Baranyai, R. Vosátka, Sz. Bősze, and J. Vinšová

P-45: (4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)ACETIC ACID DERIVATIVES AS EFFECTIVE ALDOSE REDUCTASE INHIBITORS
M. Kučerová-Chlupáčová, M. Šoltésová Prnová, J. Treml, J. Balleková, S. Michaliková, D. Haláková, M. Májeková, and M. Štefek

P-46: THE INFLUENCE OF AN AMINE MOIETY FOR HISTAMINE H3 RECEPTOR AFFINITY AND MONOAMINE OXIDASE B INHIBITORY ACTIVITY
D. Łażewska, A. Siwek, A. Olejarz-Maciej, A. Doroz-Płonka, and K. Kieć-Kononowicz

P-47: DESIGN OF NEW BIOLOGICAL ACTIVE COMPOUNDS STARTING FROM NATURAL COUMARINS
A. V. Lipeeva, E. E. Schults, D. O. Zakharov, T. S. Frolova, M. P. Dolgikh, and T. G. Tolstikova

P-48: THE SYNTHESIS AND CELLULAR EFFECTS OF NOVEL 1,3,5-TRIAZINE DERIVATIVES IN DLD AND HT-29 HUMAN COLON CANCER CELL LINES
D. Maliszewski, A. Wróbel, B. Kolesińska, Z. Kamiński, A. Tankiewicz-Kwedlo, and D. Drozdowska

P-49: NMR STRUCTURAL STUDIES AND ANTICANCER ACTIVITY OF NOVEL β-PEPTIDES
A. B. Mantsyzov, M. N. Sokolov, P. M. Ivantcova, V. I. Polshakov, and K. V. Kudryavtsev

P-50: DEPENDENCE OF ANTIMICROBIAL PROPERTIES OF ZINC OXIDE NANOPARTICLES OF THE FORM AND SIZE
G. T. Mazitova, I. A. Butorova, O. A. Nechaeva, D. A. Ivanova, and K. I. Kienskaya

P-51: SYNTHESIS OF NOVEL HETEROCYCLIC COMPOUNDS WITH POTENTIAL ANTIMYCOBACTERIAL ACTIVITY
I. Melnikova, G. Karabanovcih, L. Bartoš, J. Stolaříková, V. Klimešová, A. Hrabálek, and J. Roh

P-52: CONFRONTING CHOLINERGIC AND GLUTAMATERGIC MECHANISMS OF ALZHEIMER’S DISEASE WITH A NOVEL CLASS OF MULTITARGET AGENTS
F. Javier Pérez-Areales, A. L. Turcu, M. Barniol-Xicota, C. Pont, D. Pivetta, A. Espargaró, M. Bartolini, A. De Simone, V. Andrisano, B. Pérez, D. Vílchez, F. J. Luque, R. Sabate, F. X. Sureda, S. Vázquez, D. Muñoz-Torrero

P-53: NEW DICARBOXIMIDES TARGETING ABCF1 PROTEIN SHOW POTENT ANTICANCER AND IMMUNOMODULATORY ACTIVITIES
K. Królewska-Golińska, J. Kaźmierczak-Barańska, M. Cieślak, I. Stukan, U. Wojda, M. Napiórkowska, and B. Nawrot

P-54: Design, Synthesis and Evaluation of N-(pyridin-2-yl)benzamides and N-(pyridin-2-yl)-2-phenylacetamides as Potential Antimycobacterial Agents
D. Nawrot, M. Doležal, and J. Zitko

P-55: NEW HYBRID COMPOUNDS, DERIVATIVES OF 3-(3-METHYLTHIOPHEN-2-YL) AND (BENZO[B]THIOPHEN-2-YL)-PYRROLIDINE-2,5-DIONE WITH POTENTIAL ANTICONVULSANT ACTIVITY
J. Obniska, M. Góra, A. Czopek, and A. Rapacz

P-56: SYNTHESIS AND BIOLOGICAL ACTIVITY OF QUATERNARY SALTS OF 3-N-DODECYLAMINOQUINUCLIDINE
R. Odžak, M. Šprung, B. Soldo, A. Maravić, L. Bazina, A. Radman Kastelic, T. Hrenar, and I. Primožič

P-57: IMPACT OF THE SUPRAMOLECULAR ORGANISATION OF PYRENE – QUINOLINE CONJUGATES ON THEIR INTERACTION WITH DS – DNA
I. Orehovec, D. Glavač, I. Dokli, M. Gredičak, and I. Piantanida

P-58: IN VITRO EVALUATION OF A NEW SERIES OF BIS-PYRAZOLINES AS ANTIFUNGAL AGENTS
A. Özdemir, B. Sever, and M. D. Altıntop

P-59: IDENTIFICATION OF THIOSEMICARBAZIDES FOR INHIBITION OF TOXOPLASMA GONDII GROWTH IN VITRO
A. Paneth, L. Węglińska, A. Bekier, E. Stefaniszyn, M. Wujec, N. Trotsko, and K. Dzitko

P-60: STRUCTURE-BASED DESIGN AND SYNTHESIS OF PUTATIVE BRAFV600E INHIBITORS AS ANTICANCER AGENTS
G. E. Magoulas, E. Kritsi, M. Koufaki, D. Papahatjis, M. Zervou, and T. Calogeropoulou

P-61: N-ACETOHYDROXAMIC ACID DERIVATIVES AS METAL-CHELATING AGENTS AGAINST PARASITIC DISEASES
V. Pardali, E. Giannakopoulou, M. C. Taylor, J. M. Kelly, and G. Zoidis

P-62: NOVEL 1-AMINO-4-PHENYLBUTAN-2-OL DERIVATIVES AS MULTIFUNCTIONAL LIGANDS INHIBITING BUTYRYLCHOLINESTERASE AND β-SECRETASE
A. Pasieka, D. Panek, N. Szałaj, J. Godyń, J. Jończyk, J. Tabor, D. Knez, A. Więckowska, M. Bajda, S. Gobec, and B. Malawska

P-63: “LEGO” AND GREEN SYNTHETIC STRATEGY IN EARLY DRUG-DRUG CONJUGATES (DDCs) DESIGN
A. Pawełczyk, K. Sowa-Kasprzak, D. Olender, and L. Zaprutko

P-64: SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF N-{4-[2-(4-ARYLPIPERAZIN-1-YL) ETHYL] PHENYL}ARYLAMIDES
J. Penjišević, D. Andrić, S. Dukić-Stefanović, T. Spalholz, P. Brust, and S. Kostić-Rajačić

P-65: 2ND GENERATION OF HARMICINES AS POTENTIAL ANTIPLASMODIAL AGENTS
I. Perkovic, G. Poje, and Z. Rajic

P-66: SYNTHESIS AND EVALUATION OF NOVEL ISONIAZID-BASED COMPOUNDS AS POTENTIAL ANTIMYCOBACTERIAL AGENTS
V. Pflégr, M. Krátký, S. Bruno, J. Stolaříková, L. Horváth, Sz. Bősze, and J. Vinšová

P-67: PREPARING AND ANTIPROTEASOMAL ACTIVITY OF SALYCILAMIDES-BASED PSEUDOPEPTIDES WITH ACRYLAMIDE MOIETY
E. Pilařová, A. Imramovský, K. Pauk, Pratibha Magar, R. Jorda, and V. Kryštof

WITHDRAWN P-68: EXPANDING THE COUMARIN TOOLBOX DIRECTED AT CNS MULTITARGETING AGENTS
L. Pisani, M. Catto, M. Rullo, M. De Candia, and C. D. Altomare

P-69: A SMALL-MOLECULE INHIBITOR OF HEME OXYGENASE-1 ENHANCES METFORMIN ANTIPROLIFERATIVE ACTIVITY
V. Pittalà, M. Raffaele, L. Salerno, A. N. Fallica, V. Ciaffaglione, V. Sorrenti, and L. Vanella

P-70: Anticancer screening of series of substituted thiosemicarbazide with phenoxyacetic group
M. Pitucha, A. Korga, P. Kozyra, M. Iwan, and A. Pachuta-Stec

P-71: DIPEPTIDYL PEPTIDASE-4 INHIBITION BY FLAVONOIDS IS HINDERED IN PROTEIN RICH ENVIRONMENTS
C. Proença, M. Freitas, D. Ribeiro, S. M. Tomé, A. N. Araújo, A. M. S. Silva, P. A. Fernandes, and E. Fernandes

P-72: NEW DIARYLUREAS AS HRI ACTIVATORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND RELATED METABOLIC DISORDERS
E. Pujol, M. Zarei, J. Pizarro, M. I. Loza, J. M. Brea, M. Vázquez-Carrera, and S. Vázquez

P-73: SYNTHESIS, ANTI-PROLIFERATIVE ACTIVITY AND 3D-QSAR ANALYSIS OF NOVEL SERIES OF AMIDINO-SUBSTITUTED ARYL-BISBENZAZOLES
L. Racané, L. Ptiček, P. Grbčić, S. Kraljević Pavelić, and B. Bertoša

P-74: QUINOLINE FUMARDIAMIDES AS NOVEL QUORUM SENSING INHIBITORS
Z. Rajić, J. Z. Patel, K. Savijoki, A. Fallarero, J. Yli-Kauhaluoma, M. Beus, and B. Zorc

P-75: SYNTHESIS AND EVALUATION OF NEW PHENOLIC CINNAMIC ACID DERIVATIVES AS POTENTIAL SELECTIVE COX-2 INHIBITORS
D. Ribeiro, C. Proença, C. Varela, J. Janela, E. Tavares da Silva, E. Fernandes, and F. Roleira

P-76: RIBAVIRIN-INTERFERON INTERMOLECULAR COMPLEXES IN AQUA SOLUTIONS
M. V. Sardushkin, O. V. Zavyalova, A. M. Kusmaev, R. R. Ibragimova, and K. I. Kienskaya

P-77: DISCOVERY OF NOVEL HUMAN DNA TOPOISOMERASE II INHIBITORS THROUGH SCREENING OF BACTERIAL TOPOISOMERASE INHIBITORS’ LIBRARY
Ž. Skok, M. Durcik, N. Zidar, L. Peterlin Mašič, D. Kikelj, and J. Ilaš

P-78: SELECTIVE pERK1/2- OR β-ARRESTIN- PREFERRING 5-HT1A RECEPTOR BIASED AGONISTS WITH DIVERSIFIED THERAPEUTIC-LIKE VS. SIDE EFFECTS PROFILE
J. Sniecikowska, M. Gluch-Lutwin, A. Bucki, A. Wieckowska, A. Siwek, M. Jastrzebska-Wiesek, A. Partyka, D. Wilczynska, A. Wesolowska, M. Pawlowski, M. Varney, A. Newman-Tancredi, and M. Kolaczkowski

P-79: SYNTHESIS OF SELECTED ANALOGUES OF CURCUMIN
K. Sowa-Kasprzak, D. Olender, A. Pawełczyk, and L. Zaprutko

P-80: ON RESIN CLICK CHEMISTRY Cu (I) MEDIATED SYNTHESIS OF NOVEL OPIOID AGONISTS
A. Stefanucci, S. Pieretti, M. P. Dimmito, A. Della Valle, and A. Mollica

P-81: SYNTHESIS, CHIRAL SEPARATION AND BIOLOGICAL ACTIVITY OF (±)-trans-β-LACTAM UREAS
M. Jurin, V. Stepanić, and M. Roje

P-82: DESIGN AND SYNTHESIS OF MYOSTATIN INHIBITORY CYCLIC 22-MER PEPTIDES
C. Rentier, K. Takayama, M. Saitoh, A. Nakamura, H. Ikeyama, A. Taguchi, A. Taniguchi, and Y. Hayashi

P-83: SELECTIVE PHOTOOXYGENATION OF MYOSTATIN USING PEPTIDE-CATALYST CONJUGATE
A. Taniguchi, H. Okamoto, S. Usami, A. Taguchi, K. Takayama, and Y. Hayashi

P-84: Synthesis and tuberculostatic activity OF Substituted dihydroazolopyrimidines
Yu. A. Titova, E. S. Filatova, O. V. Fedorova, G. L. Rusinov, and V. N. Charushin

P-85: FORMULATION 2 IN 1 SULFATE-FREE BASED SHAMPOO WITH AN ANTIMICROBIAL ACTIVITY
E. V. Tolmacheva, K. I.Kienskaya, N. I. Makhova, and I. A. Butorova

P-86: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF IMIDAZOLE-BASED COMPOUNDS AS ANTIPARASITE AGENTS
V. Tudino, F. Saccoliti, V. N. Madia, A. De Leo, R. Brun, L. M. Podust, A. Messore, L. Scipione, R. Costi, and R. Di Santo

P-87: NOVEL NMDA-RECEPTOR BLOCKERS AGAINST ALZHEIMER’S DISEASE
A. L. Turcu, D. Martínez-Falguera, E. Gratacòs-Batalle, D. Soto, F. X. Sureda, and S. Vázquez

P-88: STRUCTURAL EXPLORATION OF CINNAMATE-BASED PHOSPHONIC ACIDS AS INHIBITORS OF BACTERIAL UREASE
V. Ntatsopoulos, K. Macegoniuk, A. Mucha, Ł. Berlicki, and S. Vassiliou

P-89: SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL LIPOYL/POLYPHENOLIC HYBRIDS
A. Pagoni, A. diStefano, and S. Vassiliou

P-90: A NEW FAMILY OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS: IN VITRO PROFILING AND IN VIVO EVALUATION IN A MURINE MODEL OF ACUTE PANCREATITIS
S. Vázquez, S. Codony, J. Pizarro, M. I. Loza, J. M. Brea, C. Morisseau, B. D. Hammock, and M. Vázquez-Carrera

P-91: SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL TRIMETHOPRIM ANALOGUES AS POTENTIAL MINOR GROOVE BINDERS AGENTS OF DNA, AS WELL AS INHIBITORS OF DHFR ENZYME AND HUMAN TOPOISOMERASE II
A. Wróbel, D. Maliszewski, and D. Drozdowska

P-92: NITROIMIDAZOLE-THIOSEMICARBAZIDES AS ANTIPARASITIC AGENTS
M. Wujec, P. Kołodziej, A. Paneth, A. Bogucka-Kocka, K. Dziduch, Ł. Popiołek, and K. Paruch

P-93: TOWARDS THE DEVELOPMENT OF NOVEL ANTI-HBV AGENTS: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF N-HYDROXYIMIDES AS RNASEH INHIBITORS
V. Pardali, E. Giannakopoulou, T. Edwards, J. Tavis, and G. Zoidis

P-94: MOLECULAR MODELLING STUDY OF ALLOSTERIC MODULATION OF DOPAMINE D2 RECEPTOR
J. Żuk, D. Bartuzi, and A. A. Kaczor

MEETING SECRETARIAT
GUARANT International spol. s r. o.
Na Pankráci 17, 140 21  Prague 4, Czech Republic
Phone: +420 284 001 444, Fax: +420 284 001 448
E-mail: jmmc2019@guarant.cz




© 2018 GUARANT International spol. s r. o.